{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:27:24Z","timestamp":1792639644976,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The use of drug-coated balloons (DCBs) with anti-proliferative agents in treating femoropopliteal lesions was approved in Japan in 2017. A better limb salvage rate or amputation-free rate of DCBs relative to plain old balloon angioplasty (POBA) has been reported; however, there is little evidence of the direct effect on intimal hyperplasia (IH).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 70-year-old man with chronic limb-threatening ischemia and foot gangrene had undergone bypass surgery from the left common femoral artery to the dorsalis pedis artery 2\u2009years earlier. We evaluated the bypass graft using ultrasonography and found stenosis around the proximal anastomotic site, presumably due to IH. POBA was performed every 3\u2009months due to the repeated re-stenosis of the lesion. Since using the DCB, no restenosis has been detected to date (10\u2009months).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>DCB might be an effective tool for treating re-stenosis due to IH or vein grafts that do not respond to POBA.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s40792-019-0764-9","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T16:02:42Z","timestamp":1577116962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of drug-coated balloons in treatment of stenosis of the femoral artery and vein bypass graft not responding to plain old balloon angioplasty: a case report"],"prefix":"10.1186","volume":"5","author":[{"given":"Sohei","family":"Matsuura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Akai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Isaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Hoshina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"key":"764_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jvs.2013.08.019","volume":"61","author":"CD Owens","year":"2015","unstructured":"Owens CD, Gasper WJ, Rahman AS, Conte MS, Francisco S. Vein graft failure. J Vasc Surg. 2015;61:203\u201316.","journal-title":"J Vasc Surg"},{"key":"764_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ejvs.2016.08.051","volume":"52","author":"E Saarinen","year":"2016","unstructured":"Saarinen E, Kauhanen P, S\u00f6derstr\u00f6m M, Alb\u00e4ck A, Venermo M. Long-term results of inframalleolar bypass for critical limb ischaemia. Eur J Vasc Endovasc Surg. 2016;52:815\u201322.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"764_CR3","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1001\/jama.294.24.3108","volume":"294","author":"JH Alexander","year":"2005","unstructured":"Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB, Lorenz TJ, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294:2446\u201354.","journal-title":"JAMA"},{"key":"764_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jvs.2005.12.058","volume":"43","author":"MS Conte","year":"2006","unstructured":"Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43:742\u201351 e1.","journal-title":"J Vasc Surg"},{"key":"764_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.avsg.2018.04.042","volume":"55","author":"P Bj\u00f6rkman","year":"2019","unstructured":"Bj\u00f6rkman P, Kokkonen T, Alb A, Venermo M. Drug-coated versus plain balloon angioplasty in bypass vein grafts (the DRECOREST I-study). Ann Vasc Surg. 2019;55:36\u201344.","journal-title":"Ann Vasc Surg"},{"key":"764_CR6","first-page":"217","volume":"55","author":"P Kitrou","year":"2014","unstructured":"Kitrou P, Parthipun A, Diamantopoulos A, Padayachee S, Karunanithy N, Ahmed I, et al. Paclitaxel-coated balloons for failing peripheral bypass grafts: the BYPACS study. J Cardiovasc Surg. 2014;55:217\u201324.","journal-title":"J Cardiovasc Surg"},{"key":"764_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jvs.2015.08.081","volume":"63","author":"K Linni","year":"2016","unstructured":"Linni K, Ugurluoglu A, Aspalter M, Hitzl W, H\u00f6lzenbein T. Paclitaxel-coated versus plain balloon angioplasty in the treatment of infrainguinal vein bypass stenosis. J Vasc Surg. 2016;63:391\u20138.","journal-title":"J Vasc Surg"},{"key":"764_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jvs.2017.02.032","volume":"66","author":"H Jongsma","year":"2017","unstructured":"Jongsma H, Akkersdijk GP, de Smet AAEA, Vroegindeweij D, de Vries J-PPM, Fioole B. Drug-eluting balloons and uncoated balloons perform equally to rescue infrainguinal autologous bypasses at risk. J Vasc Surg. 2017;66:454\u201360.","journal-title":"J Vasc Surg"},{"issue":"5","key":"764_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","volume":"131","author":"G Tepe","year":"2015","unstructured":"Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015;131(5):495\u2013502.","journal-title":"Circulation"},{"key":"764_CR10","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","volume":"66","author":"JR Laird","year":"2015","unstructured":"Laird JR, Schneider PA, Tepe G, Brodmann M, Zeller T, Metzger C, et al. Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am Coll Cardiol. 2015;66:2329\u201338.","journal-title":"J Am Coll Cardiol"},{"key":"764_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1406235","volume":"373","author":"K Rosenfield","year":"2015","unstructured":"Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015;373:145\u201353.","journal-title":"N Engl J Med"},{"key":"764_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1526602814564383","volume":"22","author":"D Scheinert","year":"2015","unstructured":"Scheinert D, Schulte K-L, Zeller T, Lammer J, Tepe G. Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial. J Endovasc Ther. 2015;22:14\u201321.","journal-title":"J Endovasc Ther"},{"key":"764_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","volume":"8","author":"G Tepe","year":"2015","unstructured":"Tepe G, Schnorr B, Albrecht T, Brechtel K, Claussen CD, Scheller B, et al. Angioplasty of femoral-popliteal arteries with drug-coated balloons. JACC Cardiovasc Interv. 2015;8:102\u20138.","journal-title":"JACC Cardiovasc Interv"},{"key":"764_CR14","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.116.026493","volume":"135","author":"H Schroeder","year":"2017","unstructured":"Schroeder H, Werner M, Meyer D-R, Reimer P, Kr\u00fcger K, Jaff MR, et al. Low-dose paclitaxel\u2013coated versus uncoated percutaneous transluminal balloon angioplasty for femoropopliteal peripheral artery disease. Circulation. 2017;135:2227\u201336.","journal-title":"Circulation"},{"key":"764_CR15","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","volume":"136","author":"P Krishnan","year":"2017","unstructured":"Krishnan P, Faries P, Niazi K, Jain A, Sachar R, Bachinsky WB, et al. Stellarex drug-coated balloon for treatment of femoropopliteal disease. Circulation. 2017;136:1102\u201313.","journal-title":"Circulation"},{"issue":"4","key":"764_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ccd.28048","volume":"93","author":"O Iida","year":"2019","unstructured":"Iida O, Soga Y, Urasawa K, Saito S, Jaff MR, Wang H, et al. Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial. Catheter Cardiovasc Interv. 2019;93(4):664\u201372.","journal-title":"Catheter Cardiovasc Interv"},{"key":"764_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/eci.12407","volume":"45","author":"NG VG","year":"2015","unstructured":"VG NG, Mena C, Pietras C, Lansky A. Local delivery of paclitaxel in the treatment of peripheral arterial disease. Eur J Clin Investig. 2015;45:333\u201345.","journal-title":"Eur J Clin Investig"},{"key":"764_CR18","doi-asserted-by":"publisher","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","volume":"7","author":"K Katsanos","year":"2018","unstructured":"Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7:e011245.","journal-title":"J Am Heart Assoc"},{"key":"764_CR19","unstructured":"UPDATE: Treatment of peripheral arterial disease with paclitaxel-coated balloons and paclitaxel-eluting stents potentially associated with increased mortality - Letter to health care providers | FDA. https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/update-treatment-peripheral-arterial-disease-paclitaxel-coated-balloons-and-paclitaxel-eluting. Accessed 7 Aug 2019."}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-019-0764-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40792-019-0764-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-019-0764-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:07:03Z","timestamp":1608595623000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-019-0764-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["764"],"URL":"https:\/\/doi.org\/10.1186\/s40792-019-0764-9","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"5 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethical review board of the University of Tokyo (IRB No. 3316-(4)).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave written informed consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}